Skip to main content

Table 1 Details of RA patients who collected synoviocytes

From: The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3

  Sex Age Drug (pre-operation) CRP (mg/dl) (pre-operation) ESR (mm/1 h) (pre-operation)
FLS 1 Female 43 Methotrexate 10 mg/week
Prednisolone 5 mg/week
Bredinin 450 mg/day
NSAIDs
0.09 10
FLS 2 Female 56 Adalimumab 40 mg/2 week
Methotrexate 8 mg/day
NSAIDs
0.21 5
FLS 3 Female 85 Iguratimod 50 mg/day
Bucillamine 100 mg/day
1.54 91
  1. CRP C reactive protein, ESR erythrocyte sedimentation rate